InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: maumar post# 4687

Thursday, 08/25/2016 2:51:15 AM

Thursday, August 25, 2016 2:51:15 AM

Post# of 8545
In my opinion, Roche is developing/testing a SC Perjeta without rhuph20 but used in combination with Herceptin SC.

Part 2 of the trial in actual patients involves either consecutive dosing or combination dosing. Either way, the rhuph20 in Herceptin SC will play a roll. If successful, this will add value and longevity to Herceptin SC.

The Perjeta IV dose is 420mg so Roche is testing up to three times that for a SC formulation to get equivalence.

Way too early to read anything in or out except Roche continues to see value in our partnered products.

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News